Prophylactic Eculizumab Use in Kidney Transplantation: A Review of the Literature and Report of a Case With Atypical Hemolytic Uremic Syndrome

Annals of Transplantation - United States
doi 10.12659/aot.894665
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Scientific Information, Inc.

Related search

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome

Kidney International Reports
Nephrology
2019English

Eculizumab in Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine
Medicine
2013English

Atypical Hemolytic Uremic Syndrome: A Case Report

Cureus
2019English

Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation

Kidney Medicine
Internal MedicineNephrology
2019English

Transplantation in Atypical Hemolytic Uremic Syndrome

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2010English

Resolution of Ocular Involvement With Systemic Eculizumab Therapy in Atypical Hemolytic-Uremic Syndrome

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2013English

Atypical Hemolytic Uremic Syndrome in the Setting of Complement-Amplifying Conditions: Case Reports and a Review of the Evidence for Treatment With Eculizumab

Journal of Nephrology
Nephrology
2016English

Recurrent Hemolytic Uremic Syndrome: A Case Report

International Journal of Contemporary Medical Research [IJCMR]
2018English

Atypical Hemolytic-Uremic Syndrome

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy